FDC Ltd (FDC) — Announcement | 27 August 2026

· BSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Delhi High Court grants interim stay on FSSAI mislabeling notice
💡 Investor Takeaway
Shareholders face no financial risk from the labeling issue as the court stay removes immediate regulatory pressure.

FDC Ltd announced that the Delhi High Court granted an interim stay on an FSSAI notice regarding mislabeling of its electrolyte drink products, allowing eight months to relabel stock. The filing confirms no material financial or operational impact on the company. The disclosure complies with SEBI LODR requirements and includes the court order dated August 26, 2026 as Annexure A.

📄 View Original Announcement (PDF)

About FDC Ltd (FDC)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹5,534.73 Cr P/E: 18.9 ROE: 12.8% ROCE: 17.3% Div Yield: 1.47%

View full FDC stock details →

📡 Get AI alerts when FDC files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FDC — Free

📊 More FDC filings

See all FDC filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FDC files new disclosures

Track FDC filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track FDC — Free

Free account · 2 AI queries/day